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Persistently elevated level of TNF-a has been implicated in several inﬂammatory disorders, however,
its autocrine production through TNF-a receptors signaling is poorly understood. Here we report
that simultaneous silencing of TNF-receptors, R1 and R2 by DNAzyme or siRNA suppressed TNF-a
expression more efﬁciently than silencing them individually in lipopolysaccharides (LPS) stimulated
THP-1 macrophages. Co-silencing of TNF-receptors also inhibited TNF-a induced NF-jB activation to
a higher extent. It was further observed that NF-jB inhibitor but not c-Jun N-terminal kinase inhib-
itor (SP600125) suppressed TNF-a expression. All these results suggest that TNF-a expression is reg-
ulated by synergistic signaling of TNF receptors through downstream NF-jB activation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction R2) in the production of TNF-a followed by a pro-inﬂammatoryThe pleiotropic cytokine TNF-a is crucial for the homeostasis of
the immune system, however, it also has a central role in the path-
ogenesis of several chronic inﬂammatory and autoimmune dis-
eases [1,2]. Exposure of macrophages to endotoxins such as
lipopolysaccharides (LPS) stimulates TNF-a secretion and some of
the effects of LPS are executed predominantly by the production
of TNF-a [3,4]. Nuclear factor-jB (NF-jB) acts as a key transcrip-
tion factor in the synthesis of TNF-a. A variety of stimuli including
TNF-a, LPS, IL-1, IL-2, viruses, and free radicals, result in the activa-
tion of NF-jB and consequently transcription of target genes [5]. In
human lung mast cells and murine bone marrow macrophages, it
has been demonstrated that TNF-a released upon immunological
stimulation acts as a positive autocrine feedback signal to facilitat-
ing further production of TNF-a through NF-jB activation [6,7].
However, the precise role of TNF-a receptors (TNF-R1 and TNF-chemical Societies. Published by E
rides; PMA, phorbol myristic
-terminal kinase; SP600125,
ngh Indraprastha University,
00221.signal is largely unclear.
The 10–23 DNAzymes (Dzs) are single-stranded DNA molecules
with RNA phosphodiestrase activity [8–11]. For the present study
speciﬁc Dzs were designed to silence TNF-a, TNF-R1, and TNF-R2
in human macrophage using the computer predicted secondary
structures (MFOLD; http://bioweb.pasteur.fr/seqanal/interfaces/
mfold-simple.html). The siRNAs against human TNF-a, TNF-R1,
and TNF-R2 were also used to substantiate the results obtained
by Dz silencing. We investigated the role of individual TNF receptor
in the expression of TNF-a in LPS activated THP-1 human macro-
phages using their sequential or concurrent knockdown by Dz or
siRNA. It was observed that silencing of TNF-R1 and not TNF-R2
leads to the inhibition of autocrine production of TNF-a but the
co-silencing of both TNF receptors results in a higher inhibition
of TNF-a production. The chief downstream signal potentiating
this synergistic effect seems to be TNF-a induced activation of
NF-jB through both TNF receptors thus, providing evidence of
receptor cross talk.
2. Materials and methods
2.1. Oligonucleotides
Three pairs of PCR primers for making cDNA clones to generate
short TNF-a, TNF-R1 and TNF-R2 mRNA fragments were TNF-a:lsevier B.V. All rights reserved.
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GATG-30 (RP); TNF-R1: 50-CCAAATGGGGGAGTGAGAGG-30 (FP),
50-AAAGGCAAAGACCAAAGAAAATGA-30 (RP); TNF-R2: 50-CACAT-
GCCGGCTCAGAGAATACTA-30 (FP), 50-TGTGTTGGGATCGTGTGGAC-
30 (RP) and two DNA sequencing primers 50-GTCGTTAGAACGCGGC-
TAC-30 (FP) and 50-GGTTTTCACCGTCATCACCG-30 (RP) for sequenc-
ing the inserts of Pspt18 clones and real time PCR primers for TNF-
a: 50-AGGCGCTCCCCAAGAAGACAGG-30 (FP), 50-CAGCAGGCAGA-
AGAGCGTGGTG-30 (RP); TNF-R1: 50-AGGG GTTATTGGACTGGT-30
(FP), 50-TCTGAAGCGGTGAAGGAG-30 (RP); TNF-R2: 50-GCTGTGG-
CTCCCGCTGTAG-30 (FP), 50-TCCGTGGATGAAGTCGTGTTG-30 (RP)
and the housekeeping gene glyceraldehyde 3-phosphate dehydro-
genase (GAPDH): 50-TGCCCCCATGTTCGTCA-30 (FP), 50-TTGGCC-
AGGGGTGCTAAG-30 (RP) were synthesized from TCGA (New
Delhi, India). The NF-jB consensus complementary double-
stranded oligonucleotide 50-AGTTGAGGGGACTTTCCCAGGC-30 was
part of the gel shift assay system (Promega). DNAzymes DzTNF-
a: 50-gcagaagagGGCTAGCTACAACGAgtggtggcg-30 (targeting
TNF-a), DzTNF-R1: 50-caaatcgaaGGCTAGCTACAACGAtattttgag-30
(targeting TNF-R1) and DzTNF-R2: 50-aggcttgagGGCTAGCTAC-
AACGAttccacctg-30 (targeting TNF-R2) and their corresponding
mutant DNAzymes (mDz) having TG in place of GC (underlined)
in the catalytic domain were made from Sigma, UK. Catalytic
domain of the DNAzyme sequence (written in capital letters) is
ﬂanked by two 9-nucleotide substrate recognition domains. To
resist intracellular exonuclease activity, Dzs were modiﬁed at 50
end with phosphorothioate bond and with CPG amine C7 cap at
30 end. Random hexamers for the ﬁrst strand cDNA synthesis were
part of the cDNA synthesis kit (Clontech, USA).2.2. Cell culture and transfections
The non-adherent human myelomonocytic THP-1 cells were
propagated in RPMI-1640 supplemented with 100 U/ml penicillin,
100 lg/ml streptomycin and 10% heat inactivated fetal bovine ser-
um (FBS; Biological Industries, Israel). Cells were allowed to grow
to conﬂuence at 37 C in a humidiﬁed incubator supplied with 5%
CO2.
For transfection treatments THP-1 cells were seeded at the den-
sity of 5  105 cells/ml and allowed to differentiate to macrophage
like cells by induction with 50 ng/ml of phorbol myristic acid
(PMA) for 36 h. The differentiated cells were transfected with
5 lg/ml of Dz or 1 lg/ml of siRNA against TNF-a, TNF-R1 or TNF-
R2 (Santa Cruz Biotechnology Inc.) using Lipofectamine 2000
(Invitrogen) for 7 h in OptiMEMI Reduced Serum Medium (Invitro-
gen) according to the manufacturer’s instructions. Control cells
were incubated with OPTI-MEMI alone, OPTI-MEMI and Lipofect-
amine 2000 (mock-transfected cells) or OPTI-MEMI and Lipofect-
amine 2000 plus non-silencing control mDz/scrambled siRNA (sc
siRNA). After transfection cells were supplemented with equal vol-
umes of culture medium with double FBS and stimulated with LPS
(1 lg/ml) from Escherichia coli (strain 055:B8, Sigma) to induce
TNF-a. Cells were harvested after 24 h and 4 h of LPS induction
for mRNA/protein expression and NF-jB activation studies respec-
tively. NF-jB inhibitor pyrrolidine dithiocarbamate (PDTC, Sigma)
was added to a ﬁnal concentration of 100 lM, 2 h before LPS stim-
ulation and the JNK (c-Jun N-terminal kinase) inhibitor anthrax
(1,9-cd)pyrazol-6(2H)-one (SP600125, sigma) was used at a ﬁnal
concentration of 10 lM, 30 min before LPS induction.2.3. Isolation of RNA and ﬁrst strand cDNA synthesis
Total RNA from cells was isolated by E-Z RNA isolation kit (Bio-
logical Industries, Israel). First strand cDNA synthesis was carried
out using a cDNA synthesis kit (Clontech, USA).2.4. Quantitation of mRNA by real time quantitative PCR and semi-
quantitative RT-PCR
Quantitation of TNF-a, TNF-R1 and TNF-R2 speciﬁc mRNAs from
cells were performed using light cycler system (Rotor Gene PCR-
3000, Corbett Research) with SYBR Green I ﬂuorescent dye. Gene
speciﬁc primers for speciﬁc target RNAs were used for ampliﬁca-
tion and relative quantitation were done as described by Weghofer
et al. [12] normalized to GAPDH internal control gene. The cDNA of
Dz/siRNAs untreated control cells normalized to the level of GAP-
DH mRNA have been ascribed as 100%. Semi-quantitative RT-PCR
was performed to amplify TNF-a cDNA with DNA thermalcycler
(MJ Research, Perkin Elmer) using 25 mM MgCl2, 1.25 mM dNTP,
10 pM each of the forward and reverse primer (FP – 50-CAGA-
GGGAAGAGTTCCCCAG-30 and RP – 50-CCTTGGTCTGGTAGGA-
GACG-30, product length: 325 bp) and 2.5 U of Taq DNA
polymerase. After initial denaturation at 94 C for 4 min, ampliﬁca-
tion was conducted for 35 cycles at 94 C for 30 s, annealing at
60 C for 30 s, 72 C for 60 s and a ﬁnal extension for 7 min at
72 C. The PCR product was visualized on a 1.2% agarose gel. The
density of each band (PCR product) was measured using Image
Scan and Analysis System (Alpha Innotech Corporation, USA) with
Digidoc 1201 software.2.5. Preparation of cytoplasmic and nuclear extracts
Cytoplasmic extract of THP-1 cells was prepared by the method
of Korhonen et al. [13] as described earlier [14]. Nuclear extract
was prepared following the method of Wang et al. [15] using the
same buffer systems. Protein concentrations in the cytoplasmic
and nuclear extracts were estimated by Bradford Coomassie bril-
liant blue method (Bio-Rad, Richmond, CA) using bovine serum
albumin as standard.2.6. Quantitation of TNF-a and its receptors by ELISA
The protein expression levels of soluble TNF-a, TNF-R1 and
TNF-R2 were measured by enzyme-linked immunosorbent assay
(ELISA) using speciﬁc monoclonal anti-human TNF-a, TNF-R1 and
TNF-R2 antibodies (BD Biosciences) according to the manufac-
turer’s instructions.2.7. Western blotting
The sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) fractionated cytoplasmic or nuclear extracts were
electrotransferred onto nitrocellulose membrane and probed with
TNF-a or NF-jB p65 antibodies, respectively (Santa Cruz Biotech,
USA) and developed with horseradish peroxidase conjugated sec-
ondary antibody as described by Sambrook et al. [16]. Cytoplasmic
or nuclear protein of LPS challenged cells were taken as controls for
integrated density value (IDV) to determine relative repression of
TNF-a or NF-jB, respectively.
2.8. Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSA) were carried out
using c-32P-ATP labeled double-stranded (22 bp) NF-jB consensus
oligonucleotide and nuclear extract (15 lg) from Dz transfected
and mock transfected cells in 6% of SDS–PAGE as instructed by
the supplier’s of EMSA kit (Promega, USA). Binding of the nuclear
protein of LPS challenged cells was taken as control to determine
relative binding of NF-jB with the double-stranded labeled
oligonucleotide.
Fig. 1. (A) Percent inhibition of TNF-a, TNF-R1 and TNF-R2 mRNAs in THP-1 cells by Dzs as measured by real time quantitative PCR. (B) Inhibition of TNF-a, TNF-R1 and TNF-
R2 secretion in culture supernatants of Dz transfected THP-1 cells as measured by ELISA. Data in A and B represent means ± S.D. from three sets of independent experiments,
*P < 0.05, **P < 0.01 represent signiﬁcant difference as compared with DNAzymes untreated cells.
Fig. 2. (A) Inhibition of TNF-a, TNF-R1 and TNF-R2 protein expressions by their speciﬁc siRNAs in THP-1 cells as observed by immunoﬂuorescence microscopy (magniﬁcation
10). The cells were stained with the TNF-a, TNF-R1 or TNF-R2 anti-antiserum visualized by FITC-labeled secondary antibodies after ﬁxation. (B) The mRNA expression levels
of TNF-a in THP-1 cells transfected with siRNA against TNF-a, TNF-R1 or TNF-R2. (C) Western blot of TNF-a, cytoplasmic extracts from cells transfected with siRNA against
TNF-a, TNF-R1 or TNF-R2 was probed with monoclonal antibody of TNF-a. (D) Levels of TNF-a secretion in culture supernatants of cells transfected with siRNA against TNF-a,
TNF-R1 or TNF-R2 as measured by ELISA. A representative result of three independent sets of experiments is shown in A and B. In C data represent means ± S.D. from three
sets of independent experiments, *P < 0.05, **P < 0.01 represent signiﬁcant difference as compared with supernatant from mock transfected control cells.
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Cells were differentiated on ﬁbronectin-coated culture slides
(BD Biosciences) at 70% conﬂuence, washed twice with PBS, ﬁxed
with 3.7% formalin followed by permeabilization with 0.5% Triton
X-100 and then blocked with 10% horse serum (Santa Cruz Bio-
technology, Inc.). Cells were then incubated for 4 h with desired
primary rabbit polyclonal antibody (Santa Cruz Biotechnology
Inc.) diluted 1:100 in PBS containing 1.5% goat serum. After three
washes with PBS, the cells were incubated with ﬂuorescein isothi-
ocyanate (FITC)-conjugated goat anti-rabbit secondary antibody
(1:200; Molecular Probes, Invitrogen, Carlsbad, CA) for 60 min.
Hoechst dye (Sigma, USA) was used (0.1 lg/ml) for nuclear stain-
ing. Finally, cells were washed with PBS and mounted in buffered
glycerol [90% glycerolin sodium phosphate buffer (0.1 M, pH
8.0)]. Cells were scanned under the inverted ﬂuorescence micro-
scope (Nikon, Japan) with digital camera DXM 20 1200F and
ACT-1 software.
2.10. Statistics
The values of three separate sets of experiments are expressed
as mean ± S.D. The signiﬁcance of differences from the respective
controls was tested using Student’s t-test for each paired experi-
ments. P 6 0.05 was considered as signiﬁcant.
3. Results and discussion
3.1. Cleavage of short in vitro transcripts by DNAzyme
The in vitro generated short transcripts of TNF-a (577nts), TNF-
R1 (708nts) and TNF-R2 (566nts) were cleaved into two speciﬁc
RNA fragments (P1 and P2) by their respective Dzs in concentrationFig. 3. (A) Electrophoretic mobility shift assays of NF-jB consensus double-stranded o
described in Section 2. (B) The percentage binding of NF-jB relative to control (LPS induce
jB in the nuclear extracts frommock or Dz/mDz transfected THP-1 cells probed with mon
of NF-jB level as measured by IDV. Data in B and C represent means ± S.D. from three sets
compared to mock transfected control extracts.dependent manner, mDz showed no catalytic activity (Supplemen-
tary Fig. 1). These designed Dzs did not show cross substrate RNA
cleavage activity (results not shown) as there is no sequence
homology of Dz arms of the one with the substrate RNA of the
other Dz demonstrating their cleavage speciﬁcity.
3.2. Silencing of TNF-a, TNF-R1 and TNF-R2 in LPS stimulated THP-1
cells
In LPS activated THP-1 cells DzTNF-a reduced TNF-a mRNA by
58% (P < 0.01) while DzTNF-R1 and DzTNF-R2 reduced their
respective mRNA levels to the same extent (66%, P < 0.01). Like in
in vitro, mDzs had no signiﬁcant effects on their respective tran-
scripts. Interestingly, a 26% reduction of TNF-R2 mRNA and a 19%
reduction of TNF-a mRNA were also observed in cells transfected
with DzTNF-a and DzTNF-R1, respectively (Fig. 1A). However, co-
transfection of cells with DzTNF(R1 + R2) suppressed TNF-amRNA
level by 52% (P < 0.05). Repression of the protein expressions of
TNF-a, TNF-R1 and TNF-R2 by their speciﬁc Dzs were 2.5-, 3.0-
and 2.5-folds (P < 0.01), respectively (Fig. 1B). Like mRNA expres-
sions DzTNF-a did not repress TNF-R1 protein expression appre-
ciably while that of TNF-R2 was reduced by 27% (P < 0.05). These
observations do not contradict upregulation of TNF-R2 but not
TNF-R1 by TNF-a in malignant epithelial cells [17]. A signiﬁcant
(2.43-folds, P < 0.01) repression of TNF-a protein expression was
observed with co-transfection of DzTNF-R1 and DzTNF-R2. DNA-
zyme has the stringent RNA substrate speciﬁcity and therefore, sig-
niﬁcantly higher repression of TNF-a by DzsTNF(R1 + R2) than the
individual receptor Dz could be due to the co-repression of TNF-R1
and TNF-R2 protein expressions and consequently inhibition of the
autocrine downstream receptor signaling [6].
In cells transfected with siRNA (against TNF-a, TNF-R1 or TNF-
R2) the target gene protein levels were signiﬁcantly inhibited asligo (22 mer) with nuclear proteins of mock or Dz/mDz transfected THP-1 cells as
d mock transfected nuclear extract) was determined by IDV. (C) Western blot of NF-
oclonal antibody of NF-jB p65 as described in Section 2 and the relative percentage
of independent experiments, *P < 0.05, **P < 0.01 represent signiﬁcant difference as
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efﬁciency of the siRNAs was >90% in all three cases (against TNF-a,
TNF-R1 or TNF-R2) at a concentration of 1 lg/ml after 31 h of
transfection. A reduction of 77–82% in the protein expression levels
of the target genes was observed by Western blot analysis (data
not shown). The cells treated with non-silencing scrambled siRNA
(scr siRNA) showed no change in the protein expression levels,
supporting the efﬁciency of the siRNA strategy. In the cells treated
with transfection reagent alone, those treated with no silencing
scrambled siRNA (scr siRNA) and transfected with siRNA the
expression levels of GAPDH (PCR and immunoblot) remained un-
changed, conﬁrming the high speciﬁcity of the siRNA strategy
(Fig. 2).
3.3. Effect of TNF-R1 and TNF-R2 co-silencing on TNF-a ligand
expression in LPS stimulated THP-1 cells
To conﬁrm the effect of TNF receptor silencing by Dz on the
expression of their ligand (TNF-a) the mRNA and protein expres-
sion levels in the THP-1 cells co-transfected with siRNA against
TNF-R1 and TNF-R2 were studied. The mRNA expression levels ofFig. 4. Western blot of NF-jB from the nuclear extracts from mock or siRNA transfected T
and the relative density means of NF-jB level as measured by IDV. (C) Nuclear tra
immunostaining of NF-jB using FITC-conjugated antibody. The green ﬂuorescence indica
images demonstrate nuclear co-labelling which is illustrative of nuclear translocation o
experiments is shown. Data in A represent means ± S.D. from three sets of independent
mock transfected control extract.TNF-a in siTNF-R1 transfected THP-1 cells reduced by 16.28%
(P < 0.05) as compared with the mock transfected control
(Fig. 2B). TNF-a mRNA levels showed no signiﬁcant change on siT-
NF-R2 transfection, however, co-transfection of cells with siTNF-R1
and siTNF-R2 reduced it to 57.35% (P < 0.01). Similarly, the protein
expression levels in the cells transfected with siTNF-R1 were found
to be 20.5% (P < 0.05) lower as compared to the mock control while
co-transfection of siRNA against both TNF receptors signiﬁcantly
higher suppression (up to 56%, P < 0.01) of TNF-a protein expres-
sion was observed (Fig. 2C and D). These results are in agreement
with the effects that observed with DNAzymes (Fig. 1) suggesting
critical involvement of the downstream signaling through TNF-
receptors in TNF-a expression.
3.4. Effect of TNF-R1 and TNF-R2 co-silencing on activation of
transcription factor NF-jB in LPS stimulated THP-1 cells
In THP-1 macrophages activation of NF-jB occurred within
45 min of LPS treatment. Silencing of TNF-a or its receptors had
no signiﬁcant effect on LPS induced NF-jB activation (results not
shown). NF-jB is known to induce expression of TNF-a in cellsHP-1 cells probed with monoclonal antibody of NF-jB p65 as described in Section 2
nslocation of NF-jB in mock or siRNA transfected THP-1 cells as visualised by
tes the location of p65 protein while blue ﬂuorescence indicates the nuclei. Merged
f NF-jB. Scale bar, 10 lm. A representative ﬁgure from three independent sets of
experiments, *P < 0.05, **P < 0.01 represent signiﬁcant difference as compared the
Fig. 5. Effects of TNF receptor silencing [siTNF-(R1 + R2)], NF-jB inhibitor (PDTC) or JNK inhibitor (SP600125) on TNF-a protein expression in THP-1 cells as observed by (A)
immunoﬂuorescence microscopy (magniﬁcation 40) and (B) Western blotting of TNF-a from the cytoplasmic extracts probed with monoclonal antibody of TNF-a.
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gene cluster. In this study LPS was used to induce the expression
of TNF-a in THP-1 macrophages for its maximal protein expression
within 3–4 h of the treatment. TNF-a mediated signaling through
its receptors was found to induce NF-jB activation 4 h after LPS
induction (results not shown). EMSA and Western blotting studies
performed with the nuclear extracts from Dz transfected (DzTNF-
a, DzTNF-R1 or DzTNF-R2) THP-1 cells showed a signiﬁcant reduc-
tion in the TNF-a induced NF-jB nuclear translocation (Fig. 3). The
binding of nuclear extract prepared from DzsTNF-R1 and DzsTNF-
R2 transfected cells to the NF-jB consensus oligonucleotide was
inhibited by 26.4% and 18.2%, respectively (P < 0.05) (Fig. 3B). A
much higher inhibition (52.7%, P < 0.01) of the protein binding to
consensus oligonucleotide was observed with the nuclear extracts
from cells co-transfected with DzTNF(R1 + R2). These observations
are also in agreement with the much signiﬁcant inhibition (66.1%,
P < 0.01) of TNF-a induced NF-jB nuclear translocation in Dzs
TNF(R1 + R2) co-transfected cells as observed by the Western blot
of nuclear extracts (Fig 3C). Transfection of siRNA against TNF-a
and its receptors also validate the results obtained by Dz transfec-
tions (Fig. 4). As seen in the Western blots (Fig. 4A), the individual
receptor siRNA repressed the NF-jB translocation only up to 15%
(P < 0.05) while a much signiﬁcant inhibitory effect (54%,
P < 0.01) was observed by the co-transfection of both receptor siR-
NAs. Immunoﬂuorescent studies for the NF-jB p65 localization in
the siRNA transfected cells also clearly indicated the effectiveness
of TNF receptor co-silencing in inhibiting the TNF-a induced nucle-
ar translocation of this nuclear factor (Fig. 4C). These results sug-
gest the involvement of both TNF-a receptors in activating the
nuclear translocation of NF-jB and there is an appreciable degree
of co-operativity in TNF-a receptor signaling in inducing NF-jB
activation.
3.5. Effect of PDTC and SP600125 on TNF-a expression in LPS
stimulated THP-1 cells
The TNF-receptor signaling is also involved in the activation of
JNK pathway through the formation of TRADD–RIP–TRAF-2 com-
plex [18]. Activation of a cascade of kinases results in the activation
of c-Jun NH2-terminal kinase (JNK) that phosphorylates c-Jun and
increases its transcriptional activity [18]. The transcription factors
c-Jun commonly designated as activator protein-1 (AP-1) havebeen implicated in a variety of cellular processes including prolif-
eration, differentiation and induction, as well as prevention of
apoptosis [1]. To determine the possibility of c-Jun’s contribution
to the expression of TNF-a, the protein expression levels were ana-
lysed in LPS stimulated THP-1 cells pre-treated with JNK inhibitor,
SP600125 (Fig. 5). Immunoﬂuorescent microscopy (Fig. 5A) and
Western blotting (Fig. 5B) studies with cells treated with
SP600125 showed no considerable change in TNF-a levels, how-
ever, the treatment with NF-jB inhibitor, PDTC resulted in a signif-
icant decrease (1.24-folds, P < 0.01) in the level of TNF-a. These
results imply the involvement of TNF-a induced NF-jB activation
but not c-Jun in TNF-a expression and its coordinated regulation
by TNF-R1 and TNF-R2.
Post-transcriptional silencing of TNF-a, TNF-R1 and TNF-R2
genes by their speciﬁc Dzs or siRNAs and their non-silencing by
mDzs/scr-siRNA conﬁrmed the reliability of their silencing func-
tion. Repression of TNF-a by DzTNF-a is due to the cleavage of
its RNA while that by DzsTNF(R1 + R2) is mediated through the
repression of the transcription activator protein NF-jB. Expression
level of TNF-a is maintained by the autocrine signaling by its
receptors as their simultaneous reduction by their Dzs or siRNAs
is accompanied by the signiﬁcant reduction of TNF-a production.
Further, it appears that blockage of TNF receptors will have better
effect in inﬂammatory conditions over the inhibition of TNF-a and
one of its major transcriptional activator NF-jB, as other ligand like
lymphotoxin-b can bind to TNF-receptor and exert some of the ef-
fects similar to that of TNF-a in in vivo conditions [19]. As simul-
taneous blockage of both the receptors are found to be
associated with inhibition of mRNA and protein expressions of
TNF-a closer to the extent that observed with DzTNF-a or siTNF-
a, receptor speciﬁc silencing may have greater potential to over-
come TNF-a mediated inﬂammatory or autoimmune disorders.Acknowledgements
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